ARCHIVES

Taxol Patents Reveal Bristol Strategy to Safeguard Market Against Competitors

This article is from The Cancer Letter archive.

Vol. 23 No. 26 | July 4, 1997

Download PDF Visit The Full Archive

Related Articles

Three Community Based Programs Slated for Early Phaseout, Others Modified, Provided NCAB Agrees

February 29, 1980

NY Attorney General Subpoenaes Amgen, J&J Over ESA Promotion.

May 25, 2007

Plant-Based Diet Associated With Improved Survival

April 25, 2008

Guest Editorial: MD Anderson’s Judith Smith Questions NCI Short-Term Remedy For Carboplatin Dosing

October 15, 2010

Advisors approve set-aside for alternative medicine “best case series.”

November 19, 2004

Regulations Threaten Clinical Trials Higgins contends

May 16, 1980